Automatic Pill Dispenser Market 2019 - Shares, Revenue, Analysis And Forecasts Till 2023

 As Per the Latest Market Intelligence Report Published by Market Research Future, the Automatic Pill Dispenser Market is Progressively Growing in the Forecasted Period.

The report takes a look at major developments within the global Automatic Pill Dispenser Market 2020 amidst the pandemic of the COVID-19 virus. It offers a perspective on the economic scenario and efforts to be taken post the passing of the pandemic.

Automatic Pill Dispenser Market Overview

Automatic pill dispensers are systems designed to dispense medicines without the need for supervision. This would be beneficial to the elderly and patients unable to stand in long queues. It can manage complex medication regimes and reduce waiting times at pharmacies. In addition, the presence of these machines in retirement communities and assisted living facilities can reduce the shift times of nurses. It can also lower complexities in distribution of medicines. The global automatic pill dispenser market report by Market Research Future (MRFR) takes a look at the various factors surrounding the industry and makes projections for the period of 2019 to 2024 (forecast period).

ALSO READ :  https://www.medgadget.com/2020/05/report-the-impact-of-covid-19-on-automatic-pill-dispenser-market-2020-projected-market-research-future-mrfr.html 

Automatic Pill Dispenser Market Competitive Outlook

Becton, Dickinson and Company, Yuyama Co.Ltd., McKesson Corporation, Omnicell Inc., Cerner Corporation, Swisslog Holdings AG, Capsa Healthcare, Talyst, Inc., ScriptPro LLC, and Baxter International Inc. are key players of the global automatic pill dispenser market.

Automatic Pill Dispenser Market Outlook

The global automatic pill dispenser market is set to exhibit a CAGR of 7.3% over the forecast period. It was valued at USD 1700 million in 2018.

The growing numbers of the geriatric population is one of the primary drivers of the market. The elderly find it difficult to adhere to medication refills and automated pill dispensers can lend its assistance in this regard. According to the World Health Organization (WHO), the population of the elderly can magnify to 22% of the global population by 2050.

Other factors driving market growth include adoption of pill dispensers in home care centers, rise in regulatory approvals of drugs, advances in automatic pill dispensing systems, and awareness of timely intake of medications. The use of these pill dispensing systems to reduce the rounds of doctors and nurses as well as assist patients in attaining their daily nutrient intake can bode well for the global automatic pill dispenser market.

But high costs of these systems can hamper market growth.

Automatic Pill Dispenser Market Segmentation

The global automatic pill dispenser market is segmented based on type and end user.

The global automatic pill dispenser industry is segmented by type into centralized automated dispensing system and decentralized automated dispensing system. The centralized automated dispensing system is further segmented into robotic automated dispensing systems and carousels. Furthermore, decentralized automated dispensing systems are segmented into automated unit dose dispensing system, pharmacy-based automated dispensing system, and ward-based automated dispensing system.

Based on end user, the market is segmented into home healthcare, hospital pharmacy, and retail pharmacy.

Automatic Pill Dispenser Market Regional Analysis

In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA).

The Americas had dominated the market owing to the large geriatric population in the region. The allocation of a large amount of healthcare expenditure for assisted living facilities and hospitals for dispensing medicines to the elderly can drive the market demand. According to the World Health Organization, the U.S. geriatric population can account for more than 20% of the total population in the country. High prevalence of chronic diseases such as cardiovascular diseases (CVD), diabetes, cancer, and others as well as efforts by pill dispensing manufacturers to improve the system for making it accessible for the elderly can augur favorably for the global automatic pill dispenser market.

Europe had assumed the second position in the global owing to receiving funds for research and development and technological advances in these systems.  Adherence to medications is the primary driver of the regional market. According to the National Health Service (NHS), close to USD 124 million of drugs had to be returned due to its non-utilization.

FOR MORE DETAILS -  https://www.marketresearchfuture.com/reports/automatic-pill-dispenser-market-8008 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Healthcare Asset Management Market Worldwide Key Players Forecasts By Revenue, Growth Rate Till 2023

 The data analysts at Market Research Future Reports (MRFR) have analyzed the global Healthcare Asset Management Market market.

Healthcare Asset Management Market report 2020, Size, Share, Growth, Trends and Industry Analysis By Product (Radiofrequency Identification (RFID) Devices, and Others), Application (Hospital Asset Management and Others), End-User (Hospital, Laboratory, Pharmaceutical, and Others)–Global Forecast Till 2023

Healthcare Asset Management Market Analysis 

The healthcare asset management market is likely to expand at an 18.2% CAGR between 2018-2023, reveals the new Market Research Future (MRFR) report. Healthcare asset management, simply put, is used for reducing human error in healthcare and increasing the efficient usage of available resources. It is widely used in pharmaceutical asset management and hospital asset management.

ALSO READ :  https://www.medgadget.com/2020/04/healthcare-asset-management-market-to-grow-at-18-2-cagr-by-2023-increasing-concern-about-patient-safety-to-positively-impact-healthcare-asset-management-industry-growth.html

Numerous factors are adding to the healthcare asset management market demand. Such factors, as revealed by the latest MRFR report, include aggressive strategies adopted by industry players such as acquisitions and mergers, increasing spending on R&D, increasing concern about patient safety, growing acceptance of advanced technology in healthcare, and burgeoning demand for healthcare asset management services that are easy to use.

On the contrary, issues associated with the device, patient safety, and high installation cost are factors that may limit the healthcare asset management market growth over the forecast period.  

Healthcare Asset Management Market Key Players

Key players profiled in the global healthcare asset management market report include

• Ekahau Inc.
• Stanley Black & Decker Inc.
• Sonitor Technologies
• Siemens Healthineers
• JADAK (a Novanta Company)
• Radianse
• Intelligent InSites
• Motorola Solutions Inc.
• Intelligent InSites
• Tyco Security Products.
• IBM Corporation
• Infor Inc.
• GE Healthcare
• Airista Flow
• cenTrak

Healthcare Asset Management Market Segmentation

The Market Research Future Report provides an inclusive segmental analysis of the healthcare asset management market based on end user, application, and product.

By product, the healthcare asset management market is segmented into ultrasound & infrared tags, radio frequency identification (RFID) devices, and real-time location systems (RTLS). RTLS is again segmented into services, hardware, and software. The hardware segment is again segmented into readers/interrogators and tags/badges. The RFID devices is again segmented into services, software, and hardware. The hardware segment is again segmented into accessories, readers/interrogators, and tags. The tags segment is again segmented into active tags and passive tags. Passive tags are again segmented into low frequency (LF) tags, ultra-high frequency (UHF), and high-frequency (HF) tags.

By application, the healthcare asset management market is segmented into pharmaceutical asset management and hospital asset management. Hospital asset management is again segmented into hand hygiene compliance, staff management and infection control, temperature and humidity monitoring, patient management, and equipment tracking and management. The pharmaceutical asset management is again segmented into supply chain management and drug anti-counterfeiting.

By end user, the healthcare asset management market is segmented into biotechnology, pharmaceutical companies, laboratories, and hospital/clinic.

Healthcare Asset Management Market Regional Analysis

By region, the global healthcare asset management market covers the growth opportunities and recent trends across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will spearhead the market over the forecast period. Factors adding to the growth of the healthcare asset management market in the region include the presence of a massive network of healthcare service providers, the presence of a well-developed healthcare system in the region, growing demand for new technology to prevent drug counterfeiting, and adoption of advanced technology.

The healthcare asset management market in Europe is predicted to hold the second-largest share over the forecast period. Factors adding to the healthcare asset management market in the region include growing demand for healthcare asset management services to stop drug counterfeiting, increasing research and development, and government support & funding for the healthcare sector.

The healthcare asset management market in the APAC region is predicted to grow at a quick pace over the forecast period for increasing investments in healthcare, an increasing number of expansions by industry players, increasing digitalization, and burgeoning demand for asset management software that are easy to use.

The healthcare asset management market in the MEA is predicted to have a small share over the forecast period for lack of technical knowledge, poor medical facilities, and an underdeveloped healthcare sector.  

FOR MORE DETAILS -  https://www.marketresearchfuture.com/reports/healthcare-asset-management-market-6335

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Cerebrospinal Fluid Management Devices Market Size, Share Analysis, Strategies, Revenue And Forecasts To 2023

 The data analysts at Market Research Future Reports (MRFR) have analyzed the global cerebrospinal fluid management devices market.

As per the study, the global market for cerebrospinal fluid management is estimated to record a CAGR of 5.34% and holding a value of USD 2,104.66 million by the end of 2027. The increasing prevalence of neurological diseases such as Parkinson’s disease and Alzheimer’s disease is estimated to be the most significant factor driving the global cerebrospinal fluid management market 2020. Further, the increasing case of hydrocephalus and ventriculomegaly is estimated to augment the market size.

ALSO READ :  https://www.medgadget.com/2020/08/cerebrospinal-fluid-management-devices-market-worth-usd-2104-66-million-at-a-cagr-of-5-34-by-2027-says-mrfr.html 

Also, various public and private companies are implementing various innovative technologies in the development of medical devices’ cerebrospinal fluid management. The established key players adopt tactics like these are estimated to grow the cerebrospinal fluid management devices market in the forthcoming period. In addition, the burgeoning technological development in the field of smart devices, along with the usage of AI and IoT, is another pivotal factor augmenting the market. Further, the rise in geriatric population is estimated to augment the market at the global front.

However, lack of expertise and side-effects related to the treatment is projected to obstruct the market growth in the forthcoming period.

Cerebrospinal Fluid Management Devices Market Segmentation

The global cerebrospinal fluid management devices can be segmented on the basis of age group, end-user, product, and region.

On the basis of age group, the global cerebrospinal fluid management can be segmented into pediatric, adult, and geriatric.

On the basis of end-user, global cerebrospinal fluid management can be segmented into ambulatory settings, hospitals, and research and academic institutes.

On the basis of product, the global cerebrospinal fluid management can be segmented into critical care products, shunts & valves, dural sealants, and others.

On the basis of region, the global cerebrospinal fluid management can be segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

Cerebrospinal Fluid Management Devices Market Regional Analysis

The data experts have conducted the regional analysis of the Americas, Europe, Asia-Pacific, and the Middle East & Africa at MRFR. As per the study, the global market is estimated to be dominated by the Americas. The region is excelling due to the presence of established key players. Besides, the region comprises of advanced healthcare infrastructure. Also, increasing awareness is estimated to expand the regional market. Europe is estimated to acquire the second position. The region has been witnessing a rise in chronic illness due to a change in lifestyle. Besides, the increasing support of the government is likely to affect the regional market positively. Also, the presence of established players in the region is likely to affect the market positively.

On the other hand, the APAC is estimated to take the third position. However, the APAC market is estimated to expand at the fastest pace due to the rising purchasing power. Also, increasing research and development is further likely to augment the market. The MEA region is estimated to acquire a substantial portion during the forecast period owing to the increasing R&D and the growing medical tourism. Besides, the increasing contribution of the government is further estimated to propel the regional market.

Cerebrospinal Fluid Management Devices Market Key Players

The renowned players of the global cerebrospinal fluid management devices market are

• Medtronic Plc (Ireland)
• Natus Medical Incorporated (US)
• B. Braun Melsungen AG (Germany)
• Sophia (France)
• IRRAS AB (Sweden)
• Möller Medical GmbH (Germany)
• Argi Grup (Turkey)
• Longeviti (US)
• Integra Lifesciences Corporation (US)

Cerebrospinal Fluid Management Devices Industry News

June 2020: CereVasc, a US medical device company, has raised  USD 43.9 million to help launch first-in-human clinical testing for invasive hydrocephalus procedure.

FOR MORE DETAILS -  https://www.marketresearchfuture.com/reports/cerebrospinal-fluid-management-devices-market-7196  

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Anti-Viral Drugs Market Shares Analysis, Key Development Strategies And Forecasts Till 2023

 Global Anti-viral drugs Market Report 2020, Research Study, Size, Growth, Share and Industry Analysis by application (hepatitis, HIV/AIDS, herpes, influenza and others) and by mechanism of action (nucleotide polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors and others) – Forecast to 2022

Anti-viral drugs Market Overview:

Global market for anti-viral drugs has been studied by Market Research Future (MRFR) and it revealed a possibility of surpassing worth of USD 62.67 billion by 2022. This growth would take a CAGR of 6.9% during the forecast period of 2015-2022. Various factors and dynamics are at play when it comes to an assessment of the anti-viral drugs market growth. Various factors like demand for drugs against influenza, HIV, etc. hike in investment for research projects, better technological integration across the healthcare sector, reformation in the structure of the emerging nations, and others can boost the global market.

ALSO READ :  https://www.medgadget.com/2020/04/anti-viral-drugs-market-worth-usd-62-67-billion-by-2022-at-a-cagr-of-6-9-quick-drug-development-procedure-to-ensure-growth-of-anti-viral-drugs-industry.html 

Anti-viral drugs Industry News: 

In March 2020, a report disclosed that Fujifilm’s medicine Avigan or favipiravir is showing significant promises in its battle against COVID-19. The medicine is in high demand in several countries as it has cleared two test runs with success. The Anti-viral drugs Market for this medicine is expanding as several countries are trying to get hold of a proper drug to reduce the number of people contracted and the lockdown period. A prolonged lockdown period means heavy financial toll and the market for this medicine can explore this opportunity to expand the business prospect.

Anti-viral drugs Market Segmentation:

The global report covering various details of the anti-viral drugs market has been segmented by MRFR into application and mechanism of action. This segmentation allows a detailed understanding of various market moves that can improve the decision-making process during the formation of strategies.

By application, the global market for anti-viral drugs can be segmented into influenza, HIV/AIDS, herpes, hepatitis, and others. Various pharmaceutical companies are boosting these segmental research initiatives as their primary goal is to develop a proper drug and increase their market presence.

By the mechanism of action, the report encompassing anti-viral drugs market can be segmented into reverse transcriptase inhibitors, protease inhibitors, nucleotide polymerase inhibitors, and others. The growth for each segment would get boosted by the growing intake in the healthcare sector.

Anti-viral drugs Market Regional Analysis:

The Americas would lead with a 30% share of the global Anti-viral drugs Market. This is possible due to the presence of Canada and the US. These two countries are saving a huge amount of their budgetary plan to establish a proper framework for their healthcare sector. The process is also witnessing a huge surge in the participation of pharmaceutical companies who are constantly trying to take an edge in the market to stay ahead of their peers. In Europe, pharmaceutical companies are witnessing a proper influx of funding and growing scope as the research and development centers are delivering positive results. Government investments in several associated sectors are proving to be beneficial for the market.

South Korea, Japan, China, and India are showing significant potentials in taking the market ahead. These countries have a huge market, which is luring in various global players who are expanding their businesses by launching decent measures.

Anti-viral drugs Market Competitive Landscape:

The global market for anti-viral drugs market is witnessing strong growth with the increasing participation from top-class companies like Merck & Co. Inc., Johnson & Johnson, Hoffmann-La Roche Ltd., Astra Zeneca AB, GlaxoSmithKline Plc, Gilead Sciences Inc., Novartis International AG, Abbott Laboratories, Cipla Inc., and others. These companies are banking on developing various structural methods that include mergers, better research and development facilities, increasing opportunities for expansion, hike in investment plans, and others. These companies have been profiled by MRFR and their latest actions have been includes in the report to facilitate improved strategy-making policies.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/anti-viral-drugs-market-2454 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Worldwide Bioinformatics Market Segmentation And Analysis By Recent Trends And Growth Prospects By Regions To 2023

 The global bioinformatics market is likely to grow at a whopping 19.8% CAGR between 2016- 2022, according to the new report by Market Research Future (MRFR). Bioinformatics, simply put, is a combination of biology & information technology that links biological data with the different techniques for distribution, information storage, and analysis for supporting various areas of scientific research, which also includes biomedicine. Bioinformatics utilizes software tools for data mining, data warehousing, data management, database creation, and others. Agriculture bioinformatics, animal bioinformatics, medical bioinformatics, and others are some of its major end users.  

ALSO READ :  https://www.marketwatch.com/press-release/report-the-impact-of-covid-19-on-bioinformatics-market-2020-research-study-global-size-industry-growth-trends-top-company-revenue-2020-07-13?tesla=y 

Various factors are propelling the global bioinformatics market growth. According to the new MRFR report, such factors include improved collaborations between research institutes and companies, increasing initiatives made by private and government organizations, burgeoning demand for protein sequencing and nucleic acid, increasing funds from the government, and growing use of bioinformatics in biomarker development process & drug discovery. Besides, the introduction of the latest technologies, such as cloud computing and nanopore sequencing, is also adding market growth. Besides, the biopharmaceutical innovators are preparing a viable vaccine for the novel coronavirus and are also investing a good amount of funds into the research and development to tackle the COVID-19 pandemic, which is likely to add to the market growth.  

On the contrary, scarcity of skilled personnel for ensuring the right use of bioinformatics tools, lack of integration of various data that is generated through different bioinformatics platforms, shortage of user-friendly tools at affordable prices, and lack of common data formats are factors that may limit the global bioinformatics market growth over the forecast period.  

Bioinformatics Market Competitive Analysis 

Key players profiled in the global bioinformatics market report include Dassault Systèmes, Thermo Fisher Scientific Inc., QIAGEN, Illumina, Inc., and Agilent Technologies. Industry players have incorporated several strategies to create a niche in the market, such as mergers, acquisitions, new product launches, joint ventures, and more. 

Bioinformatics Market Segmentation 

The MRFR report gives an inclusive segmental analysis of the global bioinformatics market report based on application, technology and services, and sector.  

By application, the global bioinformatics market is segmented into metabolomics, proteomics, molecular phylogenetics, transcriptomics, drug design, chemoinformatics, genomics, and others. Of these, the metabolomics segment will lead the market over the forecast period.  

By technology and services, the global bioinformatics market is segmented into sequence manipulation, sequence analysis, data warehousing, and others.  

By sector, the global bioinformatics market is segmented into agriculture bioinformatics, animal bioinformatics, medical bioinformatics, and others. Of these, the medical bioinformatics segment will have a major share in the market over the forecast period. 

Bioinformatics Market Regional Analysis 

Based on the region, the global bioinformatics market report covers the growth opportunities and recent trends across the Americas, Europe, the Asia Pacific (APAC), & the Middle East and Africa. Of these, the Americas will have the lions share in the market over the forecast period. The presence of developed technologies, increasing healthcare expenditures, and the growing biotechnology sector is adding to the global bioinformatics market growth in the region.  

The global bioinformatics market in Europe is predicted to hold the second-largest share over the forecast period followed by the APAC region. Increasing investments by the government to develop human capital, research initiatives, and infrastructure coupled with increasing healthcare expenditure in the biotechnology industry being made in India & China are adding to the global bioinformatics market growth in the region.  

The global bioinformatics market in the MEA is predicted to have the smallest share over the forecast period for the presence of poor economies, especially in the African region. Meanwhile, the Middle East will have a good share in the market for the presence of developed economies such as Qatar, Kuwait, and others.  

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/bioinformatics-market-2265 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

The Regenerative Medicine Market World Leading Key Players Revenue, Share, Analysis And Estimation Till 2022

 Regenerative Medicine Market information, By Material (Synthetic Materials, Genetically Engineered Materials, Pharmaceuticals), By Therapy (Stem Cell Biology, Cellular Therapy, Tissue Engineering), By Application (Cord Blood, Oncology, Urology, Orthopedics, Neurology, Dermatology) – Forecast till 2022 

Regenerative Medicine Market Dynamics

Global Regenerative Medicine Market can attain a rate of close to 25.4% between 2016 and 2022, considered to be the forecast timeframe in the recently launched report by Market Research Future (MRFR).

ALSO READ : https://www.medgadget.com/2020/02/regenerative-medicine-market-size-expected-to-increase-at-a-cagr-25-4-through-2022-global-industry-report-trends-development-pipeline-regional-analysis-top-companies-statistics.html   

Growth Boosters and Key Barriers

The availability of a robust product pipeline in clinical trials coupled with increasing government and private funding that facilitate research can work in favor of the regenerative medicine market. A strong product pipeline indicates the striking potential of the market in the coming years. many of the companies in the market are making sizeable investments in research and development (R&D) for product upgradation by integrating them with the latest technologies. This strategic move helps these companies fulfill all the unmet consumer demands. Besides, the renowned companies are also analyzing and developing pipeline products for cancer, cardiovascular diseases and diabetes, and neurological disorders, given the rising prevalence of these diseases around the world.

The rising number of programs in conjunction with massive investments by private agencies to enhance the development rate of the medical field also fosters market growth. To cite a reference, the National Institutes of Health or NIH is one such agency that backs the scientific research community via NIH Stem Cell Unit, NIH Stem Cell Libraries & Projects, NIH Regenerative Medicine Program, and others.

Likewise, initiatives taken by the industry players to increase the finance for R&D works wonders for the regenerative medicine market. Additionally, a number of vendors are collaborating to solidify their R&D capabilities in an attempt to commercialize creative therapies to cater to a higher number of customers locally or around the world.

Regenerative Medicine Industry Trends

Regenerative medicine is expected to gather significant attention in the healthcare sector, thanks to its rising applications as well as the substantial advancements in areas like stem cells, tissue engineering, drug discovery, nanotechnology, and gene therapy. For instance, 3D printing enjoys more demand compared to scaffold with stem cells in order to restore the structure as well as the functional properties of biological specimens.

Market Segmentation

The market for regenerative medicine has been studied with respect to segments like material, therapy and application.

The materials covered in the report are genetically engineered materials, synthetic materials, biologically derived materials, pharmaceuticals, and others.

The therapy-based segments are tissue engineering cellular therapy, stem cell biology, and others.

The market segments based on the application are oncology, cord blood, orthopedics, urology, dermatology, neurology, orthopedic, cardiovascular, and others.

Regional Outlook

Global market for regenerative medicine market seems to be expanding at a considerable pace and can immense traction in the primary regions of Latin America, Middle East & Africa, North America, Europe, and Asia Pacific (APAC).

MRFR identifies North America as the leading market for regenerative medicine, with the largest share of over 44% in the global market. The North American market is all set to achieve a lucrative growth rate of 22.3% in subsequent years, given the large number of universities and research organizations that are focused on researching a variety of stem cell-based techniques for regenerative apposition, especially in the United States (U.S.) as well as Canada.

Europe has emerged as the second-most profitable market for regenerative medicine and showcases a massive potential of achieving a growth rate of 22.5% in the coming years. Increasing cases of chronic diseases as well as conditions like Parkinson’s disease, diabetes, and Alzheimer’s disease is boosting the demand for regenerative medicines in the region and can help the market size expand substantially over the forecast timeline.

APAC is racing ahead at a rapid pace and can soon achieve the fastest growth rate in the global regenerative medicine market. Infrastructural development along with the modification of facilities in an attempt to speed up stem cell research in emerging countries benefits the market in APAC.

Regenerative Medicine Market Significant Players

Some of the significant players in the global market for regenerative include Advanced Cell Technology, Baxter International, Inc., Organogenesis, BioMimetic Therapeutics, Cook Biotech, LifeSciences, Medtronic, CryoLife, Stryker and RTI surgical, Osiris Therapeutics, Sanofi, LifeCell Kinetic Concepts, StemCellsInc, to mention a few.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/regenerative-medicine-market-2220

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Healthcare Personal Protection Equipment Market Dynamics, Forecast, Analysis And Supply Demand 2027

 

Market Research Future (MRFR) collected data on several factors including implications of covid-19 impact on microbiome sequencing services market and demographic challenges, showed how it could move forward in the coming years.

Global Healthcare Personal Protection Equipment Market is expected to cross USD 10.116 Billion by 2027 at a CAGR of 9.17%.  

Market Synopsis

Personal Protective Equipment (PPEs) are protective gear designed to safeguard the health of workers by minimizing the exposure to a biological agent. It is one of the necessary tools in preventing transmission of infectious diseases not only in treatment centers but also in various activities, e.g. cleaning, waste management and safe burials, and community care related to the outbreak. Components of PPE are goggles, face-shield, mask, gloves, coverall/gowns (with or without aprons), head cover, shoe cover, and others.

Impact of Covid-19 Outbreak on Healthcare Personal Protection Equipment Market

Healthcare Personal Protection Equipment (PPE) are protective gears that are designed to safeguard the workers by minimizing the exposure to a biological agent. PPE helps healthcare workers to fight against novel coronavirus (COVID-19). The World Health Organization (WHO) has recommended several governments worldwide to increase the production of masks, gloves, respirators, and coveralls/gowns. It also recommended that PPE manufacturers must increase their production by 40% and prioritizing their orders to countries with a high demand-supply gap.   

Several countries, including India, have considered importing PPE kits to meet its requirements from China, Singapore, and South Korea. Although a tender was rolled out last week by the government's nodal procurement agency HLL Lifecare, the government has chosen not to wait for the bids to be released, rather than source it from other countries. As of the 3rd week of April, the coronavirus (COVID-19) pandemic crossed two million cases globally. The increasing demand for hand protection, respiratory protection, and protective clothing in the healthcare industry to ensure people’s safety during the ongoing COVID-19 pandemic is expected to boost the demand for PPE.  Furthermore, the increasing government initiatives to facilitate the import of PPE is expected to drive the market growth. For instance, in March 2020, in response to the COVID-19 outbreak, the Food and Drug Administration (FDA) initiated numerous steps to improve the US stocks of PPE. A few of its measures include adjustments in import screening, flexibility to manufacturers, and creation of special mailbox service, among other provisions.

We have observed the massive impact of novel coronavirus on people’s lives over the last five months. It has also impacted various industries across the globe, eventually affecting the global economy. Some industries have experienced negative growth, whereas some industries have experienced tremendous demand and have generated massive revenues in this period. Covid 19 Impact on Healthcare Personal Protection Equipment market is the one of the positive impact sector on global industry

 

Healthcare Personal Protection Equipment Market Influencer

PPE helps healthcare workers to fight against novel coronavirus (COVID-19). The World Health Organization (WHO) has recommended the governments across the world to increase the production of masks, gloves, respirators, and coveralls/gowns. It also recommended that PPE manufacturers must increase their production by 40% and prioritizing their orders to the countries with a high demand-supply gap.

Market Drivers

• As of the 3rd week of April, coronavirus (COVID-19) pandemic crossed 2 million cases globally. The increasing demand for hand protection, respiratory protection, and protective clothing in the healthcare industry to ensure the people’s safety during the ongoing COVID-19 pandemic is expected to boost the demand for Personal Protective Equipment (PPE).

• Rapid technological advancements in the field of surgery such as High-Reliability Organizing (HRO), technical advancements, and standardizing procedures are expected to have a positive impact on the hospital sector, thereby impacting the demand for personal protective equipment positively.

• Increasing government initiatives to facilitate the import of personal protective equipment is expected to drive the market growth. For instance, in March 2020, in response to the COVID-19 outbreak, the Food and Drug Administration (FDA) initiated numerous steps to improve US stocks of personal protective equipment. The measures include adjustments in import screening, flexibility to manufacturers, and creation of special mailbox service, among other provisions.

• The emergence of local PPE manufacturers, increasing end user demand, and the rising production of cost-effective and integrated PPE is expected to boost the market growth. For instance, in India, the Union Textiles Ministry and the Health Ministry has said the government is augmenting the supplies of personal protective equipment (PPEs), including body coveralls, N-95 masks and 2-ply/3-ply surgical masks required for healthcare professionals dealing with COVID-19 cases. Furthermore, more than 130 Australian companies have responded to an urgent call to dramatically boost the manufacturing of face masks, gowns, and gloves to deal with the COVID-19 crisis.

Market Restraints

• The current global stockpile of PPE is inadequate to handle the existing and expected cases in different parts of the world, particularly for medical masks and respirators. The supply of gowns and goggles is also expected to be insufficient as the disease is spread. Surging global demand is not only driven by the increasing number of COVID-19 cases but also by misinformation, hoarding, and panic buying. The lockdown in a significant portion of the world is hampering the manufacturing of PPE.

• The high cost of raw materials (specialized clothing and other related products) is hindering the demand for PPEs in economically weak countries.

Healthcare Personal Protection Equipment Market Segmentation

By Product

• Protective Clothing: The protective clothing is further segmented into coveralls, gowns, and others. Coverall/gowns are designed to protect the torso of healthcare providers from exposure to the virus.

• Respiratory Protection: Respiratory protection is bifurcated into surgical masks, respirator masks, and others. The healthcare professionals are recommended to use surgical N95 respirators or medical respirators to protect them from the direct exposure to the COVID-19 virus.

• Head, Eye, and Face Protection: The largest segment. To prevent exposure of the eye and face from the virus, goggles or a face shield should be considered. High risk of COVID-19 and other infections through nose, eyes, and ears is among the primary reason driving the growth for this segment. The goggles must fit the contours of the user’s face and are compatible with the respirator. The use of face shields/ goggles is an integral part of standard and contact precautions for the people most at risk of COVID-19 infection.

• Protective Footwear: The use of protective footwear such as washable and disposable footwear is essential to avoid self-contamination.

• Hand protection: Hand protection is further sub-segmented into general-purpose, chemical handling, sterile gloves, and surgical. The rising awareness about hygiene and prevention from the transmission of pathogens in healthcare facilities is increasing the demand for medical gloves.

• Others

By End Use

• Hospitals & Clinics: The largest segment and expected to grow at the highest CAGR during the forecast period. The rising awareness regarding the hand protection during a viral outbreak is increasing the demand for PPEs in hospitals.

• Ambulatory Surgical Centers: The increasing number of patients visiting surgical centers is facilitating the demand for PPEs in ambulatory surgical centers.

• Academic and Research Institutes: PPEs are very effective in minimizing occupational injuries, accidents, and other hazards which otherwise result in substantial manpower and financial losses. The use of basic PPE is a must in research institutes as they protect from skin contact and contamination.

• Diagnostic Laboratories: The use of protective equipment is necessary for diagnostic laboratories to protect healthcare workers from specific hazards and hazardous materials.

• Others

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/report/covid-19-impact-healthcare-personal-protection-equipment-market

By Region

• Americas: The largest regional market. The increasing government initiatives and rising concerns in terms of health and safety of healthcare professionals is boosting the demand for the same. Moreover, the rising prevalence of COVID-19 infection is majorly contributing to the growth of this region.

• Europe: The healthcare market in Northern European economies, such as Germany, U.K., and Sweden, is expected to exhibit an increase in healthcare expenditure, thereby leading to the growth in production as well as the consumption of medical devices and products.

• Asia-Pacific: The fastest-growing regional market. Emerging market players in the region, technological advancements, rising focus of government towards healthcare facilities, and high target population in the region are among the key factors driving the market growth in the region.   

• Middle East & Africa: The high penetration of personal protective equipment in developed healthcare industries of UAE, South Africa is expected to drive the growth of the market in this region.